The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling
Open accessAbstract
Loss of miR-29 is associated with cardiac fibrosis. This study examined the role and therapeutic potential of miR-29 in mouse model of hypertension induced by angiotensin II (AngII). By using microRNA microarray, in situ hybridization, and real-time polymerase chain reaction, we found that AngII-induced cardiac fibrosis in the hypertensive heart and in cultured cardiac fibroblasts were associated with downregulation of miR-29a-c via a Smad3-dependent mechanism. In vitro knockdown of miR-29b enhanced but overexpression of miR-29b inhibited AngII-induced fibrosis, revealing a protective role of miR-29b in cardiac fibrosis in response to AngII. This was further demonstrated in vivo by the ability of overexpressing miR-29b in the mouse heart to prevent AngII-mediated cardiac fibrosis and cardiac dysfunction. Importantly, we also found that restored miR-29b in the established hypertensive heart was capable of blocking progressive cardiac fibrosis and improving cardiac dysfunction, demonstrating a therapeutic potential of miR-29b for chronic heart disease. Further studies revealed that targeting the transforming growth factor (TGF)-β1 coding sequence region, thereby inhibiting TGF-β/Smad3 signaling, could be a new mechanism by which miR-29b inhibited AngII-induced cardiac fibrosis. In conclusion, miR-29b plays a protective role in AngII-mediated cardiac remodeling and may be a therapeutic agent for cardiac fibrosis by targeting the TGF-β/Smad3 pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934
TGF-?1 and angiotensin networking in cardiac remodeling
ROSENKRANZ, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.030 · Cited by 683
Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation
Li, Z., Hassan, M. Q., Jafferji, M., Aqeilan, R. I., Garzon, R., Croce, C. M., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Lian, J. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809787200 · Cited by 589
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Self-citationLocal Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound
Taniyama, Y., Tachibana, K., Hiraoka, K., Namba, T., Yamasaki, K., Hashiya, N., Aoki, M., Ogihara, T., Yasufumi, K., & Morishita, R. (2002) · Circulation · doi:10.1161/hc1002.105228 · Cited by 470
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14190 · Cited by 426
Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.216101 · Cited by 385
Lan, H. Y., Mu, W., Nikolic-Paterson, D. J., & Atkins, R. C. (1995) · Journal of Histochemistry & Cytochemistry · doi:10.1177/43.1.7822770 · Cited by 359
Self-citationTGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214190 · Cited by 351
Lan, H. Y., Mu, W., Tomita, N., Huang, X. R., Li, J. H., Zhu, H.-J., Morishita, R., & Johnson, R. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000067632.04658.b8 · Cited by 344
Self-citationRodríguez-Vita, J., Sánchez-López, E., Esteban, V., Rupérez, M., Egido, J., & Ruiz-Ortega, M. (2005) · Circulation · doi:10.1161/01.cir.0000165133.84978.e2 · Cited by 327
Bekeredjian, R., Chen, S., Frenkel, P. A., Grayburn, P. A., & Shohet, R. V. (2003) · Circulation · doi:10.1161/01.cir.0000084535.35435.ae · Cited by 321
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Xiao, J., Meng, X.-M., Huang, X. R., Chung, A. C., Feng, Y.-L., Hui, D. S., Yu, C.-M., Sung, J. J., & Lan, H. Y. (2012) · Molecular Therapy · doi:10.1038/mt.2012.36 · Cited by 293
Self-citationMa, F., Li, Y., Jia, L., Han, Y., Cheng, J., Li, H., Qi, Y., & Du, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035144 · Cited by 271
Yang, F., Chung, A. C. K., Huang, X. R., & Lan, H. Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136531 · Cited by 258
Self-citationMicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation
Dawson, K., Wakili, R., Ördög, B., Clauss, S., Chen, Y., Iwasaki, Y., Voigt, N., Qi, X. Y., Sinner, M. F., Dobrev, D., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001207 · Cited by 252
Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart
Sun, Y. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0721 · Cited by 240
Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis
Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Bottinger, E. P., & Lan, H. Y. (2006) · Circulation Research · doi:10.1161/01.res.0000218782.52610.dc · Cited by 234
Self-citationDong, J., Wong, S. L., Lau, C. W., Lee, H. K., Ng, C. F., Zhang, L., Yao, X., Chen, Z. Y., Vanhoutte, P. M., & Huang, Y. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr459 · Cited by 177
Luna, C., Li, G., Qiu, J., Epstein, D. L., & González, P. (2009) · PubMed · Cited by 163
Hou, C., Wang, W., Huang, X. R., Fu, P., Chen, T.-H., Sheikh‐Hamad, D., & Lan, H. Y. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62297-3 · Cited by 158
Self-citationHuang, X. R., Chung, A. C. K., Yang, F., Yue, W., Deng, C., Lau, C., Tse, H., & Lan, H. Y. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147611 · Cited by 139
Self-citationKorpanty, G., Chen, S., Shohet, R. V., Ding, J., Yang, B., Frenkel, P. A., & Grayburn, P. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302532 · Cited by 122
Essential role for Smad3 in angiotensin II‐induced tubular epithelial–mesenchymal transition
Yang, F., Huang, X. R., Chung, A. C., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2721 · Cited by 109
Self-citationSmad3 mediates ANG II-induced hypertensive kidney disease in mice
Liu, Z., Huang, X. R., & Lan, H. Y. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00595.2011 · Cited by 101
Self-citationHori, Y., Kunihiro, S.-I., Sato, S., Yoshioka, K., Hara, Y., Kanai, K., Hoshi, F., Itoh, N., & Higuchi, S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1678 · Cited by 34
Almendral, J. L., Shick, V., Rosendorff, C., & Atlas, S. A. (2010) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2010.02.007 · Cited by 33
Cited by
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 361
TGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360
Getting to the Heart of the Matter: New Insights Into Cardiac Fibrosis
Leask, A. (2015) · Circulation Research · doi:10.1161/circresaha.116.305381 · Cited by 340
The fibrosis-cell death axis in heart failure
Piek, A., de Boer, R. A., & Silljé, H. H. W. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9536-9 · Cited by 301
Atrial remodeling, fibrosis, and atrial fibrillation
Jalife, J., & Kaur, K. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.12.015 · Cited by 286
Metadata
- Authors
- Zhang, Y., Huang, X.-R., Wei, L.-H., Chung, A. C., Yu, C.-M., & Lan, H.-Y.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 22
- Issue
- 5
- Pages
- 974-985
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2028425846
- Cited by
- 271
- References
- 30
- FWCI
- 22.74
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.